Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Longitudinal free-water changes in dementia with Lewy bodies

Author:Chiu, Shannon   Chen, Robin   Wang, Wei-en   Armstrong, Melissa   Boeve, Bradley   Kantarci, Kejal   Vaillancourt, David   

Session Name:P8: Movement Disorders: Atypical Parkinsonisms 1  

Topic:Movement Disorders  

Program Number:P8.007  

Author Institution:University of Florida Department of Neurology, GAINESVILLE, FL  University of Florida Department of Applied Physiology and Kinesiology, Gainesivlle, FL  University of Florida Department of Applied Physiology and Kinesiology, Gainesville, FL  Mayo Clinic Rochester Department of Neurology, Rochester, MN  Mayo Clinic Rochester Department of Neuroradiology, Rochester, MN  

Correlates of Fluctuations in Moderate-Advanced Dementia with Lewy Bodies

Author:Tholanikunnel, Tracy   Labarre, Brian   Sovich, Kaitlin   Li, Zhigang   Galvin, James   Paulson, Henry   Maixner, Susan   Manning, Carol   Fields, Julie   Lunde, Angela   Boeve, Bradley   Forsberg, Leah   Taylor, Angela   Armstrong, Melissa   

Session Name:P13: Aging and Dementia: Non-Alzheimer's Disease Dementias  

Topic:Aging and Dementia  

Program Number:P13.007  

Author Institution:University of Florida, Gainesville, FL  University of Miami, Boca Raton, FL  University of Michigan, Ann Arbor, MI  University of Virginia, Charlottesville, VA  Mayo Clinic, Rochester, MN  Lewy Body Dementia Association, Lilburn, GA  UF Department of Neurology, Gainesville, FL  

Impact of Nusinersen treatment on quality of life in adult patients with Spinal Muscular Atrophy

Author:Guerra Castanon, Felix   Deardorff, Adam   Zhao, Songzhu   Severyn, Steven   Kelly, Kristrina   Tellez, Marco   Heintzman, Sarah   Sterling, Gary   Kolb, Stephen   Arnold, David   Elsheikh, Bakri   

Session Name:P3: Neuromuscular Disease: ALS, SMA, and Other Motor Neuron Disorders 2  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P3.010  

Author Institution:Ohio State University, Columbus, OH  University of Missouri, Missouri, MO  

Lack of Rebound Disease Activity in Participants with Relapsing Multiple Sclerosis Following Placebo Run-out in the Tolebrutinib Phase 2b Trial

Author:Traboulsee, Anthony   Fox, Robert   Arnold, Douglas   Syed, Sana   Orogun, Larry   Dukovic, Deborah   Turner, Timothy   Reich, Daniel   Oh, Jiwon   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.006  

Author Institution:University of British Columbia, Vancouver, BC, Canada  Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH  NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  National Institute of Neurological Disorders and Stroke, Bethesda, MD  St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada  

MRI Outcomes from the Long-term Extension Study of Tolebrutinib in Patients with Relapsing Multiple Sclerosis: 2-Year Results

Author:Reich, Daniel   Traboulsee, Anthony   Syed, Sana   Xu, Zhixing   Turner, Timothy   Arnold, Douglas   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.012  

Author Institution:National Institute of Neurological Disorders and Stroke, Bethesda, MD  University of British Columbia, Vancouver, BC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada